We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Spectrum Pharmaceuticals will begin distributing the authorized generic version of GlaxoSmithKline’s (GSK) Imitrex Injection by November 2008 under a proposed patent settlement.